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We have previously reported that zinc affects the mitogenic process in an age- 
dependent fashion when added to lectin-stimulated lymphocytes. The present studies 
demonstrate an additional selective effect of zinc when added to Con A-activated lym- 
phocytes plus pharmacologic agents known to affect the cytoskeleton or the permeability 
of the plasma membrane. Specifically, addition of zinc did not modulate the dose- 
dependent activities of Ca2+ ionophore A23187, nigericin, or colchicine demonstrating 
that the immunologic effects of zinc do not involve modification of Ca*+ or K+ fluxes, or 
microtubule formation. By contrast, a consistent and reproducible shift in the cytochala- 
sin B dose-response curve of lymphocytes stimulated by Con A was observed when 
zinc was added. These data indicate that the effect of zinc on immune functions may be 
operating through cytochalasin B-sensitive subcellular structures, most likely microtila- 
ments. 
INTRODUCTION 
Zinc plays an important role in immune function. Zinc deficiency in animals is 
associated with abnormal development of the thymus in cattle (I), the lymphoid 
system in mice (2), and defective immune function in animals (3-5). Abnormal 
zinc metabolism is a feature of the syndrome, acrodermatitis enteropathica, a 
disease associated with T-cell functional abnormalities (6, 7). Administration of 
zinc sulphate alleviates the clinical symptoms in this condition (8). 
Zinc can act as a mitogen when added directly to lymphocyte cultures (9, 10). 
Recently we demonstrated that addition of zinc to lectin-stimulated lymphocyte 
cultures alters mitogenic responses in an age-dependent fashion (11). Lympho- 
cytes from young adults show either enhancement or no change in the mitogenic 
response on addition of zinc, whereas lymphocytes from healthy aged individuals 
show suppressed mitogenic responses in zinc-supplemented cultures. The present 
paper describes experiments performed to delineate the mechanism of the zinc 
effect on lectin-induced mitogenic responses. 
The rationale for the experiments described below is based on the following 
theoretical model. For the sake of clarity we shall keep the model very simple. 
The addition of concanavalin A (Con A) to cultures of lymphocytes initiates a 
series of events ultimately leading to DNA synthesis (Fig. 1). A number of agents 
can modulate the mitogenic process induced by Con A. These include Ca2+ 
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FIG. 1. Theoretical model for transmission of a stimulus from the lymphocyte surface to the nucleus 
following lectin binding. 
ionophore A23187 (12), the K+ ionophore, nigericin (13), colchicine, a 
microtubule-modulating agent (14), and cytochalasin B (CB) (15, 16) which ap- 
pears to affect the function of microfilaments (17). All these compounds inhibit 
mitogenic responses at higher concentrations and the inhibitory effect is lost as the 
concentration of these agents is gradually lowered. This permits one to obtain 
dose-response curves with respect to mitogenic responses when lymphocytes are 
stimulated with Con A in the presence of various amounts of these pharmacologic 
agents. Based on their vastly different biochemical effects, it is reasonable to 
assume that each of these agents acts at a different site in the sequence of events 
leading to DNA synthesis, namely A, B, C, D, etc. (Fig. 1). As the mechanisms of 
action of these compounds are well established, their ability to modify Con A- 
stimulated mitogenic responses can be used advantageously to elucidate the 
mechanism of another substance which also is known to affect the lectin-induced 
mitogenic process. 
In order to determine the site of action of an agent whose mechanism of action is 
unknown, the following approach is adopted: lymphocytes are stimulated with 
Con A to initiate DNA synthesis and a dose-response curve is generated by 
adding various amounts of a second agent whose site of action is already known 
(e.g., site B, Fig. 1). The addition of a constant amount of a third compound whose 
site of action is unknown could lead to one of two possible effects. If the site of 
action of agent 3 is the same as agent 2, the net result would be equivalent to a 
constant increment (or decrement, if agent 3 is antagonistic) in the dose of agent 2. 
This would lead to a shift in the dose-response curve of agent 2, and the direction 
of the shift depends upon whether agent 3 is synergistic or antagonistic to agent 2. 
On the other hand if the site of action of agent 3 is different from agent 2, there 
would not be a significant shift in the dose-response curve. Further, changes in 
the magnitude of the response without a shift in the curve would indicate a differ- 
ent site of action. Based on this simple model, we hypothesize that if the mecha- 
nism of action of two agents is similar there will be a shift in the dose-response 
curve and the lack of a shift indicates dissimilar mechanisms of action. This model 
can easily be expanded to tit more complex situations where an agent has more 
than one site of action. In that event a shift would be expected to occur only when 
two agents have a common site of action involving a rate-regulating step. The 
experimental results presented below show that this approach is capable of yield- 
ing informative results. 
MATERIALS AND METHODS 
Donors. Blood from young (age range: 20 to 35 years) healthy volunteer donors 
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was freshly obtained from a peripheral vein. All donors gave informed consent 
consistent with the policies of The University of Michigan and Department of 
Health, Education and Welfare. 
Isolation of lymphocytes. Peripheral blood lymphocytes (PBL) were prepared 
from fresh heparinized (20 U/ml) blood by a modification of the density gradient 
technique of Boyum (18). The mononuclear cell band was harvested and washed 
three times with Caz+- and Mg2+-free Hanks’ balanced salt solution (Grand Island 
Biological Co., Grand Island, N.Y.) and resuspended in RPM1 1640 medium 
(Grand Island Biological Co.) containing 10% heat-inactivated bovine calf serum, 
80 pg gentamicinlml (Schering Corp., Kenilworth, N.J.), and 300 pg of fresh 
glutamine/ml. 
Cell cultures. Cells were cultured in round-bottom microtiter plates at a con- 
centration of 5 x lo4 cells in 200 ~1. Mitogens, drugs, and zinc chloride were 
added to the wells at appropriate concentrations and the final volume of all cul- 
tures was adjusted to 240 ~1. The cells were incubated for 72 hr at 37°C 
in an atmosphere consisting of 5% CO, and 95% air. At 72 hr, 2 pCi of 
[methyl-3H]-thymidine, specific activity of 6.7 Ci/mmol (r3H]-thymidine, New 
England Nuclear, Boston, Mass.), was added to each well and the cultures were 
incubated for an additional 18 hr. The cells were harvested by an automatic cell 
harvester (Flow Laboratories, Rockville, Md.) and incorporation of [3H]-thymidine 
was measured by liquid scintillation spectroscopy. 
Drugs. Ionophore A23187 and nigericin were gifts from Eli Lilly Co., In- 
dianapolis, Indiana. Cytochalasin B and colchicine were obtained from Sigma 
Chemical Co., St. Louis, Missouri. Ionophore A23187, nigericin, and CB were 
dissolved in absolute ethanol at a concentration of 2 x 10e3, 1 x 10p3, and 2 x 10m2 
M, respectively and stored at 4°C. Appropriate dilutions were made up in RPMI. 
Colchicine was dissolved in RPM1 and stored frozen. ZnCl, was made up in sterile 
distilled water at a concentration of 10-l M and appropriate dilutions were made 
with RPMI. 
RESULTS 
Experiments with ionophore A23187. Figure 2 shows the Ca2+ ionophore 
A23187 dose-response curves of lymphocyte responses obtained with a single 
mitogen concentration (10 pg/ml of Con A) with the ionophore alone and in the 
presence of 5 x 1O-5 M and 1 x 1O-4 M zinc. Addition of zinc did not cause any 
significant shift in the dose-response curve compared to ionophore A23 187 alone. 
Table 1 shows a checkerboard experiment where the effect of zinc (1 x 10m4 M) on 
ionophore A23187 dose responses at three different Con A concentrations was 
examined. The data show that the addition of zinc did not bring about a shift in 
dose responses at any mitogen concentration tested. 
Experiments with nigericin. Figure 3 shows experiments similar to the above, 
with nigericin. No significant shift in nigericin dose-response curve was observed 
at two concentrations of zinc. 
Experiments with cofchicine. Figure 4 shows Con A-stimulated dose-response 
curves to colchicine with and without zinc. Once again no shift in the dose-re- 
sponse curve was obtained. Table 2 shows another checkerboard experiment using 
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FIG. 2. Effect of zinc on the ionophore A23187 dose-response curve. x, Con A (10 &ml): 0. Con 
A (IO pdrnl) + Zn 5 x 10e5 M; A, Con A (10 &ml) + Zn 1 x IO-* M. 
three mitogen concentrations. It can be seen that the addition of zinc fails to bring 
about a shift in the dose-response curve at all three mitogen concentrations 
tested. 
Experiments with cytochafusin B. In contrast to the above results, Fig. 5 dem- 
onstrates a clear shift in the dose-response curve of CB stimulated with Con A 
(10 puglml) upon the addition of zinc. The shift in the curve is best seen only at 
optimal concentrations of the mitogen. This is illustrated in Table 3. As seen in the 
last row of Table 3, the optimal mitogenic dose of Con A alone was 15 &ml for 
this individual donor. A comparison of the CB dose-response curve at the opti- 
mal Con A concentration for this donor (15 pg/ml) with and without zinc reveals 
that in the presence of zinc the maximal response occurs at a lower concentration 
of cytochalasin B, IO-* M, instead of at lo+ M with CB alone. Thus, this shift in 
maximal mitogenic response to a lower concentration of CB upon addition of zinc 
to the system reflects a synergistic effect between zinc and CB as detailed in our 
theoretical model. 
DISCUSSION 
Our previous studies showed that zinc modulates lectin-induced mitogenic re- 
sponses of human lymphocytes; further the effect was age related (11). The op- 
timum results were observed at a concentration of 1 x 1O-4 A4 zinc chloride. 
Therefore, this particular concentration was chosen for most of the experiments in 
this study. Employing various concentrations of the mitogen (5, 10, and 15 &ml 
of Con A) and two concentrations of zinc (5 x 10mS and 1 x 1O-4 M) we did not 
observe any shifts in the dose-response curves obtained with potassium 
ionophore, nigericin, calcium ionophore A23 187, and a microtubule-modulating 
agent colchicine. In contrast, a clear shift in the dose-response curve to CB was 
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I  I  I  1 
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FIG. 3. Effect of zinc on the nigericin dose-response curve. x. Con A (IO &ml); a, Con A (IO 
&ml) + Zn 5 x lo-” M: A, Con A (10 kg/ml) + Zn 1 x IO-’ M. 
mitogen concentration (10 &ml Con A). In previous studies we found that 10 
&ml of Con A was an optimal dose for lymphocytes obtained from a majority of 
individuals (11, 19). Further, under the culture conditions described, optimal 
mitogenic responses generally fall within a range of 5- 15 pg/ml of Con A. 
Employing three concentrations of Con A (5, 10, and 15 &ml) we observed that 
the shift in the blast transformation response to CB was observed best only at 
optimal mitogenic concentrations of Con A. This is consistent with our earlier 
finding that optimal modulation of the mitogenic response of lymphocytes to zinc 
occurred usually at the maximal mitogenic responses (I 1). Thus, it is essential to 
use more than one concentration of mitogen to study the effects of pharmacologic 
agents on blatsogenic responses. In contrast to the above results with a single Con 
A concentration (10 pg/ml) employing three doses of Con A we observed a shift in 
the Con A-stimulated CB dose-response curve in 10 of 13 experiments. 
On the basis of these experimental results we conclude that the effects of zinc 
on lectin-induced mitogenic responses are not exerted through alterations in Ca”+ 
or K+ fluxes or by alterations in microtubular function. The clear shift in the CB 
dose-response curves suggests that zinc might be acting on structures which are 
influenced by CB. 
Existing knowledge of the effect of CB on subcellular elements is controversial. 
Compelling evidence has been presented to emphasize that CB acts specifically 
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FIG. 4. Effect of zinc on the colchicine dose-response curve. x, Con A (10 &ml); A, Con A (10 
&ml) + Zn 1 x lo-’ M. 
through microfilaments (17). Equally persuading contradictions have been cited to 
argue that such a conclusion is premature (20). However, using rabbit pulmonary 
macrophages it was demonstrated that low concentrations of CB reversibly inhibit 
the temperature-dependent gelation of actin by actin-binding protein (21). At pres- 
ent it appears reasonable to assume that CB is exerting its effects through mi- 
crofilaments, actin, or similar structures. In addition to its effects on microlila- 
ments, CB causes an increase in Ca2+ uptake in lymphocytes treated with mito- 
gens (22). However, the inability of zinc to affect the ionophore A23187 dose- 
response curve indicates that the effect of zinc is not mediated through alterations 
in Ca2+ fluxes. 
A shift in the dose response of CB, as demonstrated, may also result if the 
uptake of CB is increased by zinc. However, in such an event the shift would be 
expected to occur at all three mitogen concentrations tested, but Table 3 shows 
that a clear shift occurs only at optimal concentration of the mitogen, a concentra- 
tion where zinc exerts its specific differential effect as discussed above. Another 
mechanism one might consider is the effect CB may have on the transport of small 
molecules (23) and the possibility that zinc might affect the transport of these 
molecules in a synergistic manner. Although this possibility cannot be excluded 
we would like to place greater emphasis on the cytoskeletal system for several 
reasons: (a) one of the effects of CB on transport function is the enhancement of 
Ca”+ uptake (22) and our experiments show that zinc does not operate by this 
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Cylochalasin B Concentration @ 
FIG. 5. Effect of zinc on the cytochalasin B dose-response curve. x, Con A (10 &ml); A, Con A 
(10 &ml) + Zn 1 x lob4 M. 
mechanism, thus excluding at least one transport property as not being relevant to 
the shift we observe with zinc; (b) zinc has been demonstrated to have a direct 
effect on red cell membranes (24) and the red cell membrane has high-affinity 
binding sites for CB (23), thus precedence exists for suggesting that both these 
agents might be acting on the lymphocyte membrane through the cytoskeleton; (c) 
experiments in rats indicate that mobility of the surface membrane of lymphocytes 
is altered with age and it is postulated that this alteration might reflect changes in 
the cytoskeleton (25) (our findings are consistent with such a hypothesis); and 
finally (d) it is very likely.that alterations in the transport of small molecules might 
be secondary to changes in the cytoskeletal function which are not perceptible by 
morphological studies. 
Another intriguing finding which might support the similarity between the ac- 
tion of zinc and CB is the observation that CB inhibits rosette formation of sheep 
erythrocytes with thymus-derived peripheral blood lymphocytes but not with 
thymocytes (26). This observation is analogous to our finding that zinc has differ- 
ential effects on lymphocytes obtained from young and aged individuals (11). 
Several studies have suggested that membrane changes, reduction in the 
number of receptors, or changes in receptor sensitivity may be involved in the 
age-related decline of the immune response (27, 28). Similarly, receptor concen- 
trations of various hormones were found to decrease with increasing age (29). 
Microfilaments have profound influence on membrane mobility, receptor expres- 
sion, and sensitivity (30, 31). Thus any change in the structure and function of the 
microfilaments and related structures will have significant effects on all 
aforementioned parameters. Our previous observations that zinc has differential 
effects on lymphocytes obtained from young and aged individuals and the present 
evidence that zinc might act through microfilaments, actin, or similar structures 
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the mechanism of immunological senescence. If our future studies implicate 
changes in actin or similar elements in the depressed immunologic responses in 
aging, the existence of these elements in almost every cell in the organism offers 
an attractive unifying theory for the cellular basis of aging. 
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